Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
Manuscript Number:
22-0361R1
Author(s):
Albert Amran, Avram S. Bukhbinder, Ryan Coburn, Omar Hasan, Xiaoqian Jiang, Yejin Kim, Yaobin Ling, Kamal N. Phelps, Srivathsan Ramesh, Rosemarie E. Schmandt, Paul E. Schulz, Qian Xiao
Disclosures
Albert Amran
Nothing to Disclose
Avram S. Bukhbinder
Nothing to Disclose
Ryan Coburn
Nothing to Disclose
Omar Hasan
Nothing to Disclose
Xiaoqian Jiang
Nothing to Disclose
Yejin Kim
Nothing to Disclose
Yaobin Ling
Nothing to Disclose
Kamal N. Phelps
Nothing to Disclose
Srivathsan Ramesh
Nothing to Disclose
Rosemarie E. Schmandt
Nothing to Disclose
Paul E. Schulz
Consulting Fees:
Occasional advisory panels for Lilly, Acadia, and Biogen.
Lecture Fees:
Occasional disease state education talks for Lilly, Acadia, and Biogen.
Patents/Royalties
I serve as an expert witness for medical malpractice cases and other types of cases. None related to this paper.
Not sure where to put this, but i am on about 12 NIH grants, none related to this study. And i have about 12 treatment trials funded by many pharmaceutical companies, including Lilly, Acadia, Biogen, Roche, UCB, etc. None are related to this paper, in my opinion.